18 Sep Conversion of Loan Notes

Posted at 17:00h in Board, Novacyt Group, Products by

Paris, France and Camberley, UK – 18 September 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT) an international specialist in clinical diagnostics, announces that, pursuant to the Convertible Bonds with Warrants Funding Programme announced on 26 April 2019, it has issued a tranche of new ordinary shares of €1/15 each (“Ordinary Shares”) to Negma Group Limited following the receipt of conversion notices. Further details are set out below.

https://novacyt.com/wp-content/uploads/2019/09/23.-Novacyt-Note-Conversion-23-18.09.19-ENGLISH-1.pdf